M Douglas Winship - Net Worth and Insider Trading
M Douglas Winship Net Worth
The estimated net worth of M Douglas Winship is at least $2 Million dollars as of 2024-11-13. M Douglas Winship is the VP, Regulatory Operations of Catalyst Pharmaceuticals Inc and owns about 74,131 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $2 Million. Details can be seen in M Douglas Winship's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that M Douglas Winship has not made any transactions after 2015-10-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of M Douglas Winship
M Douglas Winship Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, M Douglas Winship owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of M Douglas Winship’s form 4 insider trades.
Insider Ownership Summary of M Douglas Winship
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CPRX | Catalyst Pharmaceuticals Inc | 2015-10-23 | V.P. of Regulatory Operations |
M Douglas Winship Latest Holdings Summary
M Douglas Winship currently owns a total of 1 stock. M Douglas Winship owns 74,131 shares of Catalyst Pharmaceuticals Inc (CPRX) as of October 23, 2015, with a value of $2 Million.
Latest Holdings of M Douglas Winship
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
CPRX | Catalyst Pharmaceuticals Inc | 2015-10-23 | 74,131 | 23.04 | 1,707,978 |
Holding Weightings of M Douglas Winship
M Douglas Winship Form 4 Trading Tracker
According to the SEC Form 4 filings, M Douglas Winship has made a total of 0 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 22,800 shares on October 23, 2015, which brought M Douglas Winship around $76,152.
Insider Trading History of M Douglas Winship
- 1
M Douglas Winship Trading Performance
GuruFocus tracks the stock performance after each of M Douglas Winship's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by M Douglas Winship is 90.36%. GuruFocus also compares M Douglas Winship's trading performance to market benchmark return within the same time period. The performance of stocks bought by M Douglas Winship within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how M Douglas Winship's insider trading performs compared to the benchmark.
Performance of M Douglas Winship
M Douglas Winship Ownership Network
Ownership Network List of M Douglas Winship
Ownership Network Relation of M Douglas Winship
M Douglas Winship Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
M Douglas Winship is the V.P. of Regulatory Operations of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include VP Development & Management Steve Miller , Chief Commercial Officer Carmen Jeffrey Del , and Chief Medical Officer Gary Ingenito .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, M Douglas Winship made no insider transaction in Catalyst Pharmaceuticals Inc (CPRX). Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 230,000 shares made by Gary Ingenito , a net sale of 90,000 shares made by David S Tierney , and a net sale of 190,000 shares made by Steve Miller .
In summary, during the past 3 months, insiders sold 165,000 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 165,000 shares. During the past 18 months, 741,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 741,406 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
M Douglas Winship Mailing Address
Above is the net worth, insider trading, and ownership report for M Douglas Winship. You might contact M Douglas Winship via mailing address: 220 Miracle Mile, Suite 234, Coral Gables Fl 33134.